Getein Biotech (SHSE:603387) Total Stockholders Equity : ¥2,646 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Getein Biotech Total Stockholders Equity?

Getein Biotech's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,646 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Getein Biotech's Book Value per Share for the quarter that ended in Mar. 2024 was ¥5.22. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Getein Biotech's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.24.

Getein Biotech Total Stockholders Equity Historical Data

The historical data trend for Getein Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getein Biotech Total Stockholders Equity Chart

Getein Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,624.97

1,837.99

2,106.40

2,482.47

2,559.32

Getein Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															2,603.19	2,500.69	2,510.47	2,559.32	2,646.09

Getein Biotech (SHSE:603387) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Getein Biotech's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2646.087	-	0)	/	507.154
	=	5.22

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Getein Biotech's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(640.43	+	3.823)	/	2646.087
	=	0.24

Getein Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Getein Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Getein Biotech (SHSE:603387) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getein Biotech Inc (SHSE:603387) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9 Bofu Road, Luhe District, Nanjing, CHN, 211505

Website

http://www.bio-gp.com.cn

Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.

Executives

Su En Kui	Director
Yan Bin	Director
Kong Ting Ting	Director
Xu Xing De	Director
Su En Ben	Director

Getein Biotech (SHSE:603387) Headlines

No Headlines